These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36647666)

  • 21. Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients.
    Cheng L; Liang Z; Liu F; Lin L; Zhang J; Xie L; Yu M; Sun F
    Front Pharmacol; 2023; 14():1126580. PubMed ID: 36860301
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients.
    Liang Z; Yu M; Liu Z; Liu F; Jia C; Xiong L; Dai Q; Qin S; Cheng L; Sun F
    Front Pharmacol; 2022; 13():835871. PubMed ID: 35462904
    [No Abstract]   [Full Text] [Related]  

  • 23. Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis.
    Brouwer AE; Teparrukkul P; Pinpraphaporn S; Larsen RA; Chierakul W; Peacock S; Day N; White NJ; Harrison TS
    J Infect Dis; 2005 Aug; 192(4):681-4. PubMed ID: 16028138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
    Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
    J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole.
    Mafuru M; Wu S; Mayala H; Msengwa Z; Phillip A; Mgone C
    Pharmgenomics Pers Med; 2021; 14():1379-1389. PubMed ID: 34754219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients.
    Takahashi T; Smith AR; Jacobson PA; Fisher J; Rubin NT; Kirstein MN
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypokalemia and Hyponatremia in Adult Patients Receiving Voriconazole Therapeutic Drug Monitoring.
    Cheng L; Liu Z; Yu M; Lin L; Xiong L; Dai Q
    J Clin Pharmacol; 2024 Apr; 64(4):461-468. PubMed ID: 37910022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.
    Chang CC; Omarjee S; Lim A; Spelman T; Gosnell BI; Carr WH; Elliott JH; Moosa MY; Ndung'u T; French MA; Lewin SR
    J Infect Dis; 2013 Nov; 208(10):1604-12. PubMed ID: 23908492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents.
    Huang L; Ye H; Qu J; Liu Y; Zhong C; Tang G; Liu Y; Huang Y; Lv X
    BMC Infect Dis; 2015 Aug; 15():333. PubMed ID: 26268786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
    Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
    AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study.
    Zhou L; Li M; Li H; Guo Z; Gao Y; Zhang H; Qin F; Sang Z; Xing Q; Cheng L; Cao W
    Front Cell Infect Microbiol; 2023; 13():1157944. PubMed ID: 37565064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
    Chang HH; Lee NY; Ko WC; Lee HC; Yang YH; Wu CJ; Chang CM
    Int J Infect Dis; 2010 Apr; 14(4):e348-50. PubMed ID: 19665407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.
    Karthaus M; Lehrnbecher T; Lipp HP; Kluge S; Buchheidt D
    Ann Hematol; 2015 Apr; 94(4):547-56. PubMed ID: 25697592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Drug Monitoring of Voriconazole in Patients with End-Stage Liver Disease.
    Wu Z; Jiang M; Yan M; Li G; Zeng Z; Zhang X; Li N; Jiang Y; Gong G; Zhang M
    Ther Drug Monit; 2024 Feb; 46(1):89-94. PubMed ID: 38192036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections.
    Miao Q; Tang JT; van Gelder T; Li YM; Bai YJ; Zou YG; Wang LL; Shi YY
    Medicine (Baltimore); 2019 Jan; 98(3):e14137. PubMed ID: 30653146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New guinea pig model of Cryptococcal meningitis.
    Kirkpatrick WR; Najvar LK; Bocanegra R; Patterson TF; Graybill JR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3011-3. PubMed ID: 17562797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials.
    Pullen MF; Hullsiek KH; Rhein J; Musubire AK; Tugume L; Nuwagira E; Abassi M; Ssebambulidde K; Mpoza E; Kiggundu R; Akampurira A; Nabeta HW; Schutz C; Evans EE; Rajasingham R; Skipper CP; Pastick KA; Williams DA; Morawski BM; Bangdiwala AS; Meintjes G; Muzoora C; Meya DB; Boulware DR
    Clin Infect Dis; 2020 Oct; 71(7):e45-e49. PubMed ID: 31912875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection.
    Naranbhai V; Chang CC; Durgiah R; Omarjee S; Lim A; Moosa MY; Elliot JH; Ndung'u T; Lewin SR; French MA; Carr WH
    AIDS; 2014 Mar; 28(5):657-66. PubMed ID: 24451162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventricular and lumbar cerebrospinal fluid analysis in 77 HIV-negative patients with Cryptococcal meningitis who received a ventriculoperitoneal shunt.
    Dong Q; Huang Z; Yu P; Song E; Chen Z; Qin F
    Sci Rep; 2022 Dec; 12(1):21366. PubMed ID: 36494487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.